Evidence map›Paper›PMID 26343845›Full record

ArticleBrain research2015

Characterization of cerebral microvasculature in transgenic mice with endothelium targeted over-expression of GTP-cyclohydrolase I.

Anantha Vijay R Santhanam, Livius V d'Uscio, Zvonimir S Katusic

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Endothelium-specific amyloid precursor protein deficiency causes endothelial dysfunction in cerebral arteries.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anantha Vijay R SanthanamDepartments of Anesthesiology and Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Livius V d'UscioDepartments of Anesthesiology and Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Zvonimir S KatusicDepartments of Anesthesiology and Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: katusic.zvonimir@mayo.edu.
Mayo Clinic · US

Funding

Endothelial Dysfunction In The Cerebral CirculationR01HL111062 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2012 to 2016
$2.3M
Mechanisms of endothelial repair after vascular injuryR01HL091867 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2009 to 2012
$1.5M
NHLBI NIH HHS HL111062NHLBI NIH HHS R01 HL091867NHLBI NIH HHS R01 HL111062
6 · The paper itself

Abstract

Tetrahydrobiopterin (BH4) is a critical determinant of nitric oxide (NO) production by nitric oxide synthase (NOS) in the vascular endothelium and its biosynthesis is regulated by the enzymatic activity of GTP-cyclohydrolase I (GTPCH I). The present study was designed to determine the effects of endothelium-targeted overexpression of GTPCH I (eGCH-Tg) on murine cerebral vascular function. Endothelium targeted over-expression of GTPCH I was associated with a significant increase in levels of BH4, as well as its oxidized product, 7,8-dihydrobiopterin (7,8-BH2) in cerebral microvessels. Importantly, ratio of BH4 to 7,8-BH2, indicative of BH4 available for eNOS activation, was significantly increased in eGCH-Tg mice. However, expression of endothelial NOS, levels of nitrate/nitrite--indicative of NO production--remained unchanged between cerebral microvessels of wild-type and eGCH-Tg mice. Furthermore, increased BH4 biosynthesis neither affected production of superoxide anion nor expression of antioxidant proteins. Moreover, endothelium-specific GTPCH I overexpression did not alter intracellular levels of cGMP, reflective of NO signaling in cerebral microvessels. The obtained results suggest that, despite a significant increase in BH4 bioavailability, generation of endothelial NO in cerebral microvessels remained unchanged in eGCH-Tg mice. We conclude that under physiological conditions the levels of BH4 in the cerebral microvessels are optimal for activation of endothelial NOS and NO/cGMP signaling.

Indexed as

Analysis of VarianceAnimalsBiopterinsCatecholaminesCerebral ArteriesCyclic GMPEndothelium, VascularGene Expression RegulationGTP CyclohydrolaseMiceMice, Inbred C57BLMice, TransgenicMicrovesselsNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IIIBiopterinsCatecholaminesCyclic GMPGTP CyclohydrolaseNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IIIsapropterinSuperoxidesCerebral microvesselEndothelial nitric oxide synthaseGTP-cyclohydrolase ITetrahydrobiopterin

Identifiers

PMID26343845
PMCPMC4637228
OpenAlexW1931724913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.